David B. Corry

The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells.

Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency.

Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease.

Emerging immune targets for the therapy of allergic asthma.

Gamma-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D(4) formation in vivo.

Environmental contributions to the allergic asthma epidemic.

A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease.

Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy.

Frequency dependence of respiratory system mechanics during induced constriction in a murine model of asthma.

16. Immunologic lung disease.

Differential requirement for CD18 in T-helper effector homing.

Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: implications in asthma.

Airway glycoprotein secretion parallels production and predicts airway obstruction in pulmonary allergy.

Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma.

Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines.

Homing alone? CD18 in infectious and allergic disease.

Help for interpretation of cardiopulmonary exercise testing.

An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema.

Endogenous attenuation of allergic lung inflammation by syndecan-1.

Resolving a case of split personality.

The future of asthma therapy: integrating clinical and experimental studies.

Eotaxin and obesity.

7. Control of allergic airway inflammation through immunomodulation.

Interactions between leukotriene C4 and interleukin 13 signaling pathways in a mouse model of airway disease.

Asthma: pathology and pathophysiology.

A general method for bead-enhanced quantitation by flow cytometry.

Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation.

Cytokine storm and an anti-CD28 monoclonal antibody.

Promise and pitfalls in animal-based asthma research: building a better mousetrap.

Antielastin autoimmunity in tobacco smoking-induced emphysema.

A new mechanism regulating the initiation of allergic airway inflammation.

Interleukin 25 promotes the initiation of proallergic type 2 responses.

A new link to airway obstruction in asthma.

Software for interpreting cardiopulmonary exercise tests.

Discovery of novel markers in allergic lung inflammation through proteomic-based technologies.

Developmental control of integrin expression regulates Th2 effector homing.

Mouse let-7 miRNA populations exhibit RNA editing that is constrained in the 5'-seed/ cleavage/anchor regions and stabilize predicted mmu-let-7a:mRNA duplexes.

At last, an immune organ we can call our own?

Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma.

Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice.

Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice.

Toward a comprehensive understanding of allergic lung disease.

Smoking gun: mature dendritic cells in human lung provide clues to chronic obstructive pulmonary disease.

Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema.

Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.

Proinflammatory role for let-7 microRNAS in experimental asthma.

Respiratory tract allergic disease and atopy: experimental evidence for a fungal infectious etiology.

Seeking common pathophysiology in asthma, atopy and sinusitis.

Dual protective mechanisms of matrix metalloproteinases 2 and 9 in immune defense against Streptococcus pneumoniae.

Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers.

Proteinases as molecular adjuvants in allergic airway disease.

Fungal chitin from asthma-associated home environments induces eosinophilic lung infiltration.

Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease.

Fungi linking the pathophysiology of chronic rhinosinusitis with nasal polyps and allergic asthma.

Cigarette Smoke Induction of Osteopontin (SPP1) Mediates TH17 Inflammation in Human and Experimental Emphysema.

High prevalence of asthma in HIV-infected adults: New insights.